Trump’s MFN Drug Pricing Policy Is Reshaping Pharmaceutical Markets
The United States is seeking to curb pharmaceutical expenditure by incorporating international price referencing into public health insurance programs.
Welcome Carina von Schantz-Fant!
Carina joined Medaffcon’s Medical Affairs team in September 2016
Carina holds a Doctor of Philosophy degree and has more than 15 years of experience in genetics, cell biology and molecular biology.
Previously, Carina has worked at the Institute of Molecular Medicine Finland (FIMM) and at the National Institute for Health and Welfare (THL).
A warm welcome to Tintti!
